HXNetRetatrutide
Ordered Retatrutide from HXNet? Mail in a sample (US only) and let us test it for free.
Test my supplyHXNet Retatrutide shows mixed evidence: purity usually clears the purity-focus bar, but large fill misses and a Feb identity/zero-quantity failure cap confidence. Recent passes have batch IDs; late-May -37% fill is the key caveat.
Corporate records anchor HXNet to Hebei Xunou while the old domain is dead and sales have shifted into forum/Pastebin lanes. The report follows the HXTNT/KIRA/KARA reseller split, Janoshik chain-of-custody gaps, and documented refund/contamination disputes.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including HXNet rows.
Cancel anytime
Ordered Retatrutide from HXNet? Mail in a sample (US only) and let us test it for free.
Test my supplyAbout HXNet test results from Finnrick
HXNet is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 11 peptides and 165 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible HXNet peptides in this dataset are Tirzepatide (52 tests), Semaglutide (5 tests) and BPC-157 (9 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 165 recent tests.
Ordered Retatrutide from HXNet? Mail in a sample (US only) and let us test it for free.
Test my supply